Jade de Oliveira

Dr. Jade de Oliveira

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2020 in Life Sciences
Verified
Journal Article
Closed access
MAMeysam Amidfar
Meysam Amidfar
JOJade de Oliveira
Jade de Oliveira
EKEwa Kucharska
Ewa Kucharska
JBJosiane Budni
Josiane Budni
YKYong-Ku Kim
Yong-Ku Kim

4 November 2021 in Frontiers in Neuroscience
Verified
Journal Article
Open access
GPGabriela Cristina de Paula
Gabriela Cristina de Paula
HBHenver S. Brunetta
Henver S. Brunetta
DEDaiane F. Engel
Daiane F. Engel
JGJoana M. Gaspar
Joana M. Gaspar
LVLicio A. Velloso
Licio A. Velloso
MMMaria Monsalve
Maria Monsalve
Graphical An illustrative scheme summarizing the main outcomes in Swiss mice fed high-fat diet (HFD), with their exact time of onset of changes in the hippocampus. An increase in the expression of proinflammatory cytokines, together with the permeability of the blood–brain barrier was detected after 2 days of HFD. Even in the first week of dietary intervention, memory and learning impairment, depressive-like behavior, and synaptic changes were observed at 3, 5, and 7 days, respectively. Later hippocampal alterations (after 4 weeks of HFD consumption) include mitochondrial dysfunction and astrocytic activation.

1 December 2011 in Neuroscience
Verified
Journal Article
Closed access
JOJade de Oliveira
Jade de Oliveira
MHM.A. Hort
M.A. Hort
EME.L.G. Moreira
E.L.G. Moreira
VGV. Glaser
V. Glaser
RRR.M. Ribeiro-Do-Valle
R.M. Ribeiro-Do-Valle
MMMaria Monsalve
Maria Monsalve

28 September 2021 in Cells
Verified
Journal Article
Open access
PDF file
JOJade de Oliveira
Jade de Oliveira
EKEwa Kucharska
Ewa Kucharska
MGMichelle Lima Garcez
Michelle Lima Garcez
MRMatheus Scarpatto Rodrigues
Matheus Scarpatto Rodrigues
JQJoão Quevedo
João Quevedo
JBJosiane Budni
Josiane Budni
Alzheimer’s disease (AD) is the leading cause of dementia worldwide. Most AD patients develop the disease in late life, named late onset AD (LOAD). Currently, the most recognized explanation for AD pathology is the amyloid cascade hypothesis. It is assumed that amyloid beta (Aβ) aggregation and deposition are critical pathogenic processes in AD, leading to the formation of amyloid plaques, as well as neurofibrillary tangles, neuronal cell death, synaptic degeneration, and dementia. In LOAD, the causes of Aβ accumulation and neuronal loss are not completely clear. Importantly, the blood–brain barrier (BBB) disruption seems to present an essential role in the induction of neuroinflammation and consequent AD development. In addition, we propose that the systemic inflammation triggered by conditions like metabolic diseases or infections are causative factors of BBB disruption, coexistent inflammatory cascade and, ultimately, the neurodegeneration observed in AD. In this regard, the use of anti-inflammatory molecules could be an interesting strategy to treat, delay or even halt AD onset and progression. Herein, we review the inflammatory cascade and underlying mechanisms involved in AD pathogenesis and revise the anti-inflammatory effects of compounds as emerging therapeutic drugs against AD.

27 October 2020 in Journal of Alzheimer’s Disease
Verified
Journal Article
Open access
JOJade de Oliveira
Jade de Oliveira
Daiane Fatima EngelDaiane Fatima Engel
Daiane Fatima Engel
GPGabriela C. de Paula
Gabriela C. de Paula
DSDanúbia B. dos Santos
Danúbia B. dos Santos
JLJadna B. Lopes
Jadna B. Lopes
MMMaria Monsalve
Maria Monsalve
Background: Evidence has revealed an association between familial hypercholesterolemia and cognitive impairment. In this regard, a connection between cognitive deficits and hippocampal blood-brain barrier (BBB) breakdown was found in low-density lipoprotein receptor knockout mice (LDLr–/–), a mouse model of familial hypercholesterolemia. Objective: Herein we investigated the impact of a hypercholesterolemic diet on cognition and BBB function in C57BL/6 wild-type and LDLr–/–mice. Methods: Animals were fed with normal or high cholesterol diets for 30 days. Thus, wild-type and LDLr–/–mice were submitted to memory paradigms. Additionally, BBB integrity was evaluated in the mice’s prefrontal cortices and hippocampi. Results: A tenfold elevation in plasma cholesterol levels of LDLr–/–mice was observed after a hypercholesterolemic diet, while in wild-type mice, the hypercholesterolemic diet exposure increased plasma cholesterol levels only moderately and did not induce cognitive impairment. LDLr–/–mice presented memory impairment regardless of the diet. We observed BBB disruption as an increased permeability to sodium fluorescein in the prefrontal cortices and hippocampi and a decrease on hippocampal claudin-5 and occludin mRNA levels in both wild-type and LDLr–/–mice treated with a hypercholesterolemic diet. The LDLr–/–mice fed with a regular diet already presented BBB dysfunction. The BBB-increased leakage in the hippocampi of LDLr–/–mice was related to high microvessel content and intense astrogliosis, which did not occur in the control mice. Conclusion: Therefore, LDLr–/–mice seem to be more susceptible to cognitive impairments and BBB damage induced by exposure to a high cholesterol diet. Finally, BBB disruption appears to be a relevant event in hypercholesterolemia-induced brain alterations.

25 January 2015 in Archives of Toxicology
Verified
Journal Article
Closed access
PDF file
ASAlessandra Antunes dos Santos
Alessandra Antunes dos Santos
ANAline Aita Naime
Aline Aita Naime
JOJade de Oliveira
Jade de Oliveira
DCDirleise Colle
Dirleise Colle
DSDanúbia Bonfanti dos Santos
Danúbia Bonfanti dos Santos
Marcelo FarinaMarcelo Farina
Marcelo Farina